Activities of life: The copd patient

COPD: Journal of Chronic Obstructive Pulmonary Disease

Volumn 6, Issue 3, 2009, Pages 192-200

  Bourbeau, Jean ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Chronic Obstructive Pulmonary Disease; COPD; Daily activity; Exercise; Respiratory

Indexed keywords

CHRONIC OBSTRUCTIVE LUNG DISEASE; DAILY LIFE ACTIVITY; DISABILITY; DISEASE EXACERBATION; FUNCTIONAL STATUS; HEALTH EDUCATION; HEALTH STATUS; HUMAN; IMMOBILIZATION; LIFESTYLE MODIFICATION; MOTION ANALYSIS SYSTEM; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PULMONARY REHABILITATION; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SELF CARE;

ACTIVITIES OF DAILY LIVING; DISABILITY EVALUATION; DISEASE PROGRESSION; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 70350445133     PISSN: 15412555     EISSN: 15412563     Source Type: Journal    
DOI: 10.1080/15412550902902638     Document Type: Review

References (55)

1. Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest Feb 2000; 117(2 Suppl):1S-4S.
2. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med Apr 2001; 163(5):1256-1276.
3. Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J Jun 2004; 23(6):932-946.
4. O'Donnell D, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, Kaplan RM, Keenan S, Lacasse Y, Maltais F, Road J, Rocker G, Sin D, Sinuff T, Voduc N. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2007 update. Can Respir J 2007; 14(Suppl B):5B-32B.
5. Global Initiative for Chronic Obstructive Lung Disease. Executive Summary: Global Strategy for the Diagnosis, Management, and Prevention of COPD. http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=996. Accessed May 5, 2007.
6. Nicolson P, Anderson P. Quality of life, distress and self-esteem: a focus group study of people with chronic bronchitis. Br J Health Psychol Sep 2003; 8(Pt 3):251-270.
7. Bailey PH. The dyspnea-anxiety-dyspnea cycle-COPD patients' stories of breathlessness: "It's scary /when you can't breathe". Qual Health Re Jul 2004; 14(6):760-778.
8. Williams V, Bruton A, Ellis-Hill C, McPherson K. What really matters to patients living with chronic obstructive pulmonary disease? An exploratory study. Chron Respir Dis 2007; 4(2):77-85.
9. Hajiro T, Nishimura K, Tsukino M, Ikeda A, Oga T. Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease. RespirMed Sep 2000; 94(9):841-846.
10. O'Donnell DE, Aaron S, Bourbeau J, Hernandez P, Marciniuk D, Balter M, Ford G, Gervais A, Goldstein R, Hodder R, Maltais F, Road J. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease-2003. Can Respir J May-Jun 2003; 10 Suppl A:11A-65A.
11. World Health Organization. International classification of functioning, disabilities, and health: ICF.Geneva, 2001.
12. U.S. Department of Health and Human Services. Physical activity and health: A report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion; 1996.
13. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax Sep 2006; 61(9):772-778.
14. Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH, Goldstein RS. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002(3):CD003793.
15. Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med. Mar 1 2007; 175(5):458463.
16. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med.Sep 1 2001; 164(5):770-777.
17. Walker PP, Burnett A, Flavahan PW, Calverley PM. Lower limb activity and its determinants in COPD. Thorax Aug 2008; 63(8):683-689.
18. Paffenbarger RS, Jr., Blair SN, Lee IM, Hyde RT. Measurement of physical activity to assess health effects in free-living populations. Med Sci Sports Exerc Jan 1993; 25(1):60-70.
19. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J May 2006; 27(5):1040-1055.
20. Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van StaverenWA. A physical activity questionnaire for the elderly.Med Sci Sports Exerc Aug 1991; 23(8):974-979.
21. Washburn RA, Smith KW, Jette AM, Janney CA. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol Feb 1993; 46(2):153-162.
22. Caspersen CJ, Bloemberg BP, Saris WH, Merritt RK, Kromhout D. The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol Jun 1 1991; 133(11):1078-1092.
23. Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R. Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil Oct 2005; 86(10):1979-1985.
24. Rennard S, Decramer M, Calverley PM, Pride NB, Soriano JB, Vermeire PA, Vestbo J. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J Oct 2002; 20(4):799-805.
25. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. May 1 2005; 171(9):972-977.
26. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med Sep 15 2007; 176(6):532-555.
27. Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med Apr 1 2008; 177(7):743-751.
28. Strassels SA, Smith DH, Sullivan SD, Mahajan PS. The costs of treating COPD in the United States. Chest Feb 2001; 119(2):344-352.
29. Eisner MD, Yelin EH, Trupin L, Blanc PD. The influence of chronic respiratory conditions on health status and work disability. Am J Public Health Sep 2002; 92(9):1506-1513.
30. Leidy NK, Haase JE. Functional performance in people with chronic obstructive pulmonary disease: a qualitative analysis. ANS Adv Nurs Sci Mar 1996; 18(3):77-89.
31. Odencrants S, Ehnfors M, Grobe SJ. Living with chronic obstructive pulmonary disease: part I. Struggling with meal-related situations: experiences among persons with COPD. Scand J Caring Sci Sep 2005; 19(3):230-239.
32. Lomborg K, Bjorn A, Dahl R, Kirkevold M. Body care experienced by people hospitalized with severe respiratory disease. J Adv Nurs May 2005; 50(3):262-271. (Pubitemid 40545441)
33. Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest May 2000; 117(5 Suppl 2):398S-401S.
34. Wedzicha JA. Mechanisms of exacerbations. Novartis Found Symp 2001; 234:84-93; discussion 93-103.
35. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med May 1998; 157(5 Pt 1):1418-1422.
36. Miravitlles M, Ferrer M, Pont A, Zalacain R, Alvarez-Sala JL, Masa F, Verea H,Murio C, Ros F, Vidal R. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax May 2004; 59(5):387-395.
37. Spencer S, Jones PW. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax Jul 2003; 58(7):589-593.
38. Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Felez MA, Sunyer J, Anto JM. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med Sep 15 2001; 164(6):1002-1007.
39. Donaldson GC, Seemungal TA, Bhowmik A,Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax Oct 2002; 57(10):847-852.
40. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax Dec 2000; 55(12):1000-1006.
41. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med May 2000; 161(5):1608-1613.
42. Garcia-Aymerich J, Farrero E, FelezMA, Izquierdo J, Marrades RM, Anto JM. Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax Feb 2003; 58(2):100-105.
43. Bourbeau J, Ford G, Zackon H. Impact on patient's health status following early identificaiton of a COPD exacerbation. Eur Respir J 2007; 30:907-913.
44. Barr RG, Bourbeau J, Camargo CA, Ram FS. Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax Oct 2006; 61(10):854-862.
45. Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med Feb 22 2007; 356(8):775-789. (Pubitemid 46294610)
46. Aaron SD, Vandemheen KL, Fergusson D,Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M. Tiotropium in combination with placebo, salmeterol, or fluticasonesalmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med Apr 17 2007; 146(8):545-555. (Pubitemid 351650535)
47. Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med Oct 9 2008; 359(15):1543-1554.
48. Lacasse Y, Wong E, Guyatt GH, King D, Cook DJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet Oct 26 1996; 348(9035):1115-1119.
49. Maltais F, LeBlanc P, Jobin J, Berube C, Bruneau J, Carrier L, Breton MJ, Falardeau G, Belleau R. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med Feb 1997; 155(2):555-561. (Pubitemid 27085801)
50. Bourbeau J, Nault D, Dang-Tan T. Self-management and behaviour modification in COPD. Patient Educ Couns Mar 2004; 52(3):271-277.
51. Adams SG, Smith PK, Allan PF, Anzueto A, Pugh JA, Cornell JE. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med Mar 26 2007; 167(6):551-561. (Pubitemid 46513224)
52. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, Singh R, Collet JP. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med Mar 10 2003; 163(5):585-591. (Pubitemid 36314346)
53. Tashkin DP. Multiple dose regimens. Impact on compliance. Chest May 1995; 107(5 Suppl):176S-182S.
54. Turner J, Wright E, Mendella L, Anthonisen N. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest Aug 1995; 108(2):394-400.
55. McAuley E. Self-efficacy and the maintenance of exercise participation in older adults. J Behav Med Feb 1993; 16(1):103-113. (Pubitemid 23051441)